Features | Partner Sites | Information | LinkXpress
Sign In
JIB
BioConferenceLive
GLOBETECH PUBLISHING

Switch to CAD Technology Greatly Improves Lab-On-A-Chip Capability

By BiotechDaily International staff writers
Posted on 12 May 2014
The lab-on-a-chip holds potential for reducing cost of medical diagnostics while expanding access to health care. Now scientists have developed computer aided design (CAD) software to enable far more than one or two tests on a single chip.

In the near future healthcare professionals may be able to routinely run clinical lab tests almost instantly on a digital microfluidic machine about the size of credit card. These lab-on-a-chips (LOCs) would not only be quick—results available in minutes—but also inexpensive and portable. They could be used at point-of-care, and even at long distance from the nearest medical clinic.

But as powerful as they may be, they could be far better, said Shiyan Hu, associate professor of electrical and computer engineering at Michigan Technological University (MTU; Houghton, MI, USA). Current LOCs can generally run no more than a test or two because the chips are designed manually. If the LOCs were made using computer-aided design (CAD), you could run dozens of tests with, for example, a single drop of blood. “In a very short time, you could test for many conditions,” said Prof. Hu; “This really would be an entire lab on a chip.” With PhD student Chen Liao, Prof. Hu has taken the first step. “We have developed software to design the hardware,” he said.

Their work, described in, and featured on the cover of, the March, 2014, edition of the journal IEEE Transactions on Nanobiosciences, focuses on routing a droplet of blood or other fluid through each test on the chip efficiently while avoiding contamination. A key part in LOC CAD is physical-level synthesis. It includes the LOC placement and routing, where placement is to determine the physical location and the starting time of each operation, and routing is to transport each droplet from the source to the destination.

“It has taken us four years to do the software, but to manufacture the LOC would be inexpensive,” said Prof. Hu; “The materials are very cheap, and the results are more accurate than a conventional lab’s.” Prof. Hu plans to fabricate their own biochip using their software.

Related Links:

Michigan Technological University



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Microcomputed tomography images (top) and histology images (bottom) of the knees of mice fed a very high fat diet containing omega-3 fatty acid supplement (left) or only omega-6 fatty acids (right) after a knee injury. The omega-6 diet showed abnormal bone remodeling and calcified tissue formation in the joint (white arrow). The omega-6 diet also showed significant loss of cartilage (red staining, yellow arrowhead) and increased joint inflammation (Photo courtesy of Duke University).

Dietary Omega-3 Fatty Acids Moderate Severity of Osteoarthritis in a Mouse Model

Researchers working with an osteoarthritis (OA) obese mouse model found that the fat content of the animals' diet contributed more to the development or arrest of OA than did body weight.... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel

Vaccine Being Developed for Heart Disease Close to Reality

The world’s first vaccine for heart disease is becoming a possibility with researchers demonstrating significant arterial plaque reduction in concept testing in mice. Klaus Ley, MD, from the La Jolla Institute for Allergy and Immunology (LA Jolla, CA, USA), and a vascular immunology specialist, is leading the vaccine... Read more

Business

view channel

A Surge in IPOs Revitalize Investments for the Global Pharma and Biotech

Anti-infective drugs, oncology, and pharmaceutical contract laboratories attract the most investment up to now. The intensified private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008–2010, witnessed a waning post-2010. However, the decline in deals... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.